The Nuclear Medicine Department at Burjeel Cancer Institute offers cutting-edge diagnostic and therapeutic services using radioactive substances to diagnose and treat cancer. Our expert team of nuclear medicine specialists uses advanced imaging techniques such as PET-CT and SPECT-CT to detect cancers at their earliest stages and monitor treatment progress. In addition, we provide targeted radionuclide therapies for specific types of cancer, ensuring personalized and precise treatment options.
Conditions We Treat
Diagnostic Services
Therapeutic Services
In addition to diagnostic imaging, we offer radionuclide therapies for the treatment of specific cancers, including:
Radioactive Iodine Therapy (I-131)
Used to treat thyroid cancer by targeting and destroying cancerous thyroid tissue with minimal impact on surrounding healthy tissue.
Peptide Receptor Radionuclide Therapy (PRRT)
A targeted treatment for neuroendocrine tumors that delivers radiation directly to cancer cells, minimizing damage to healthy tissue.
Radionuclide Therapy for Bone Metastases
Using radium-223 or other radioactive substances to target and treat bone metastases in patients with advanced prostate, breast, or other cancers, helping to relieve pain and slow the progression of cancer.
Selective Internal Radiation Therapy (SIRT)
A form of internal radiation therapy used to treat liver cancer or liver metastases by delivering radiation directly to the tumor through the bloodstream.
Our Approach to Treatment
Diagnostic and Monitoring Tools
Supportive Care and Patient Services
Advanced Nuclear Medicine Techniques
Patient Journey
